Deglycosylation Avibactam
| CAS No. | DA | Cat. No. | BCP31868 |
| Name | Deglycosylation Avibactam | ||
| Synonyms | NXL104; NXL-104; NXL 104; | ||
| Formula | C6H13N3O5S | M. Wt | 239.25 |
| Description | Avibactam is a non-β-lactam β-lactamase inhibitor antibiotic, which is a new drug application for avibactam in combination with ceftazidime, and was approved by the FDA on February 25, 2015, for treating complicated urinary tract and complicated intra-abdominal Infections caused by antibiotic resistant-pathogens, including those caused by multi-drug resistant gram-negative bacterial pathogens. | ||
| Related Products | Avibactam Impurity（Avibactam Impurity） 1192491-61-4（Avibactam sodium） AVH（Avibactam sodium hydrate） 1192500-31-4（Avibactam） | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.